Project Details
Description
GOG-286B: A Randomized Phase II/III Study Of Paclitaxel/Carboplatin/Metformin (Nsc#91485) Versus Paclitaxel/Carboplatin/Placebo As Initial Therapy for Measurable Stage III Or IVa, Stage IVb, Or Recurrent Endometrial Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 4/1/16 → 2/28/19 |
Funding
- NRG ONCOLOGY FOUNDATION, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.